The Research Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between the Virtual Physiological Human Institute (VPH) and industries engaged in predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.

The key goals of this group are:

  • Promotion of in silico medicine in Horizon 2020;
  • Working towards the creation of a Public Private Partnership (PPP) on in silico medicine;
  • Creating links between the VPH Membership and Avicenna Industry Members


Priorities in 2018

→ Further develop a comprehensive position for Avicenna on what is needed in EU research;
→ Launch of the new Avicenna Alliance internship scheme;
→ A core focus of the VPH membership is on the FET Flagship on ageing and on shaping this Flagship programme;
→ Contribute to the three upcoming Avicenna Alliance White Papers

Working group leader:

  • Liesbet Geris
  • Executive Director, VPH Institute
  • Professor, University of Liège & KU Leuven (Belgium)

Avicenna Alliance news

The European Commission published its Beating Cancer Plan

On 3 February the European Commission published its much-awaited Beating Cancer Plan. The Plan develops proposals and key initiatives for...

find out more ›

Alliance provides feedback on the creation of a European Health Data Space

On 3 February, the Avicenna Alliance has submitted its feedback to the inception impact assessment on the European Health...

find out more ›

European Commission publishes evaluation on Directive on patients' rights in cross-border healthcare

On 15 January, the European Commission published an evaluation and fitness check roadmap on the...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up